Mechanical ventilation

Critical Care Ventilators Market to Witness Superior Growth due to COVID-19 Spread | Technavio

Retrieved on: 
Wednesday, October 28, 2020
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20201028005687/en/
    Technavio has announced its latest market research report titled Global Critical Care Ventilators Market 2020-2024 (Graphic: Business Wire)
    This report provides a detailed analysis of the critical care ventilators market by product (portable ventilators and mounted ventilators) and geography (North America, Europe, Asia, and ROW).
  • The growing focus toward non-invasive ventilation in critical care units is a key trend in the global critical care ventilators market which will lead to significant market growth.
  • North America was the largest market for critical care ventilators in 2019, and the region is expected to offer several growth opportunities to market vendors during the forecast period.
  • The critical care ventilators market is segmented into two segments based on products comprising of portable ventilators and mounted ventilators.

Freeman Lung Institute First in Region to Provide MediPines AGM100® Advanced Respiratory Monitoring System

Retrieved on: 
Tuesday, October 27, 2020

The MediPines respiratory monitoring system, AGM100, provides direct respiratory measurements allowing the medical team to better understand how well their patients' lungs are functioning.

Key Points: 
  • The MediPines respiratory monitoring system, AGM100, provides direct respiratory measurements allowing the medical team to better understand how well their patients' lungs are functioning.
  • The MediPines AGM100 is an advanced respiratory monitoring system designed to assess and detect a patient's gas exchange efficiency and provide a comprehensive respiratory assessment in under two minutes.
  • "We are very excited to support the innovative Freeman Lung Institute to improve respiratory patient care with our device's advanced monitoring capabilities," stated Steve Lee, CEO of MediPines.
  • Freeman Lung Institute, a locally owned and not-for-profit clinic, provides comprehensive care for a wide range of pulmonary conditions including:

ProvideGx® and Baxter Healthcare Secure the Supply of Critical Shortage Drug for COVID-19 Patients Requiring Ventilation

Retrieved on: 
Monday, October 26, 2020

The drug has been on the U.S. Food and Drug Administrations (FDA) drug shortage list since April of 2020, when large numbers of COVID-19 patients were admitted to hospitals and received mechanical ventilation.

Key Points: 
  • The drug has been on the U.S. Food and Drug Administrations (FDA) drug shortage list since April of 2020, when large numbers of COVID-19 patients were admitted to hospitals and received mechanical ventilation.
  • However, severe cases of COVID-19 still require mechanical ventilation, and these cases are on the rise across the country.
  • The partnership between Premier and Baxter Healthcare will help stabilize the supply of one of these drugs for the benefit of the patients who are counting on ventilation to save their lives.
  • Dexmedetomidine is a front-line drug in our intensive care units, especially during this time when were dealing with higher numbers of hospitalized COVID-19 patients.

aTyr Pharma Announces Completion of Enrollment in Phase 2 Clinical Trial of ATYR1923 in COVID-19 Patients with Severe Respiratory Complications

Retrieved on: 
Monday, October 26, 2020

The study enrolled a total of 32 patients at hospitals in the U.S. and Puerto Rico, exceeding the target enrollment of 30 patients.

Key Points: 
  • The study enrolled a total of 32 patients at hospitals in the U.S. and Puerto Rico, exceeding the target enrollment of 30 patients.
  • The Phase 2 clinical trial is a randomized, double blind, placebo-controlled study of ATYR1923 in hospitalized COVID-19 patients with severe respiratory complications who do not require mechanical ventilation.
  • aTyr is currently enrolling a proof-of-concept Phase 1b/2a trial evaluating ATYR1923 in patients with pulmonary sarcoidosis, a form of interstitial lung disease.
  • In response to the COVID-19 pandemic, aTyr is conducting a Phase 2 clinical trial with ATYR1923 in COVID-19 patients with severe respiratory complications.

Positive Airway Pressure Market: CPAP, APAP, BiPAP - Global Growth, Trends, and Forecast 2020-2025 with Koninklijke Philips, ResMed, Smiths Group, 3B Medical, and Apex Medical Dominating - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 21, 2020

The "Positive Airway Pressure Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Positive Airway Pressure Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.
  • Also, increased awareness of sleep apnea and risk factors such as cardiovascular indications and high blood pressure are expected to fuel the PAP market throughout the forecast period.
  • Still, only 20% of them were diagnosed with the treatment, which drives the market growth in the forecast period.
  • Some of the companies which are currently dominating the market are Koninklijke Philips NV, ResMed Inc., Smiths Group PLC, 3B Medical Inc., and Apex Medical Corp.

Dräger Wins 2020 Frost & Sullivan Global Technology Innovation Leadership Award

Retrieved on: 
Wednesday, October 21, 2020

Telford, PA, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Drger, an international leader in the fields of medical and safety technology, today announced that Frost & Sullivan has recognized the company as a global technology innovation leader in the ventilation industry.

Key Points: 
  • Telford, PA, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Drger, an international leader in the fields of medical and safety technology, today announced that Frost & Sullivan has recognized the company as a global technology innovation leader in the ventilation industry.
  • Frost & Sullivan selected Drger for its 2020 Global Technology Innovation Leadership Award due to the companys pioneering work to enhance patient safety and expedite recovery through innovative ventilator clinical protocols, continuous improvements in ventilation technology, and best-in-class services/support, training and continuing education.
  • We are honored to have been chosen by Frost & Sullivan for this prestigious award, said President and CEO for Drger in North America, Lothar Thielen.
  • In 2017, Drger won the Frost & Sullivan North American Medical Ventilation Product Leadership Award, and in 2014 the Frost & Sullivan Best Practices Award in the Growth Excellence Leadership category for Mechanical Ventilation Equipment.

InventHelp Inventor Develops CPAP Tent (DHM-552)

Retrieved on: 
Monday, October 19, 2020

She developed the PAP CAVE that may allow users to move more freely for increased comfort that may lead to a better night's sleep.

Key Points: 
  • She developed the PAP CAVE that may allow users to move more freely for increased comfort that may lead to a better night's sleep.
  • This invention would eliminate the cumbersome and confining mask while also reducing the incidence of the CPAP machine being pulled over during the night.
  • The original design was submitted to the Durham sales office of InventHelp.
  • 19-DHM-552, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext.

Diaphragm Pacing can Enhance Recovery and Weaning from Mechanical Ventilation (MV) in Cardiac Surgery

Retrieved on: 
Thursday, October 1, 2020

These patients all underwent extensive cardiac surgery, and range in age from 24 to 72 years old.

Key Points: 
  • These patients all underwent extensive cardiac surgery, and range in age from 24 to 72 years old.
  • Once in the intensive care unit, stimulation began generating a fused diaphragm contraction preventing diaphragm atrophy and Ventilator Induced Diaphragm Dysfunction (VIDD).
  • These findings are important because prolonged ventilation and intubation after cardiac surgery is an important complication which can lead to other problems.
  • Continued experience with DP can help enhance the recovery and weaning from a ventilator after cardiac surgery.

Devin Singletary, Marquez Valdes-Scantling And Richie James Debut GO² Devices, The Only Mouthguard Proven To Increase Oxygen Levels

Retrieved on: 
Thursday, October 1, 2020

The device applies a known physiological principle called Positive End Expiratory Pressure, or "PEEP", a physiological technique used in the medical field for several years.

Key Points: 
  • The device applies a known physiological principle called Positive End Expiratory Pressure, or "PEEP", a physiological technique used in the medical field for several years.
  • I see the tremendous value in increasing oxygen levels on the field and the GO works, plain and simple.
  • GO Devicesis proven to increase endurance by 6% and increase VO2 max by 4% with independent research conducted atHouston Methodist HospitalsandTexas A&M University.
  • "GO aims to help athletes across the globe achieve their highest potential and with their help spreading the word, we'll do just that."

Independent multi-center trial shows that Getinge's NAVA ventilation mode shortens time of mechanical ventilation by almost 35% for adult ICU patients

Retrieved on: 
Wednesday, September 30, 2020

According to the NAVIATOR trial, NAVAsignificantly increased the number of ventilator-free days and shortened the time of mechanical ventilation (MV) for adult patients with acute respiratory failure (ARF)1.

Key Points: 
  • According to the NAVIATOR trial, NAVAsignificantly increased the number of ventilator-free days and shortened the time of mechanical ventilation (MV) for adult patients with acute respiratory failure (ARF)1.
  • "This large multi-center independent trial supports that NAVA has significant positive clinical effects for adult patients in intensive care units (ICU).
  • Fewer days in the ICU also translates to a significantly improved health economy, enabling hospitals to free up precious ICU beds and resources" says Jens Viebke, President Acute Care Therapies at Getinge.
  • The ventilation mode is based on monitoring of the neural output generated by the respiratory centers in the brain.